Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
13.830USD
-0.990-6.68%
Market hours 11/05, 13:25（ET）
1.08BMarket Cap
LossP/E TTM
Today
-6.68%
5 Days
+12.99%
1 Month
+9.07%
6 Months
+29.86%
Year to Date
+11.35%
1 Year
+22.39%
Key Figures
14.785Open
15.150High
44.63KVolume
LossP/E TTM
5.73P/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
14.820Prev. Close
13.740Low
627.02KTurnover
LossP/E Static
1.01P/B
0.00%Div Yield TTM
-13.00%ROA
20.49052wk High
0.05Volume Ratio
-6.94MNet Profit
77.80MShares
-6.4654EPS TTM
1.23Beta
-38.64%ROE
8.70052wk Low
9.51%Amplitude
54.59%Gross Margin
1.08BMarket Cap
-0.86Reward/Risk
3.81%Risk Rate
Integra Lifesciences Holdings Corp's Score
0.29vs previous score
Forecast6.50
Financial Health7.35
Technical6.28
Valuation Dimensions8.11
Institutional Confidence10.00
Risk Assessment5.01
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Integra Lifesciences Holdings Corp Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Integra Lifesciences Holdings Corp Latest Earnings Call Transcripts
Integra LifeSciences (IART) Q3 2026 Earnings Call: Cincinnati Disruption Weighs on Outlook
Integra LifeSciences Q3 2026 earnings call: revenue rose 2.3% to $411.2 million, while the Cincinnati disruption drove lower full-year guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.19/0.56
Revenue / Forecast
411.18M/414.12M
Integra Lifesciences Holdings Corp Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolIART
Number of employees4396
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 12.09% |
| TRU ST Partnership, L.P. | 10.95% |
| Rubric Capital Management LP | 9.97% |
| Vanguard Portfolio Management, LLC | 4.74% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 37.70% |
| Investment Advisor | 36.17% |
| Hedge Fund | 17.97% |
| Corporation | 10.95% |
Related Instruments
-2.57%
-3.18%
-2.02%
-4.08%
-3.11%
-1.08%
-2.59%
-1.44%
+0.25%
-1.71%
-1.15%
-3.16%
-3.75%
+0.62%
+0.10%
-3.93%
-2.90%
-8.75%
-0.17%
-2.30%Popular Instruments
51729.700
-1634.900 (-3.06%)
26787.000
-1646.900 (-5.79%)
7384.800
-307.600 (-4.00%)
12797.000
-1.000 (-0.01%)
58110.000
-4911.000 (-7.79%)
6202.900
-103.000 (-1.63%)
89.975
+1.934 (+2.20%)
342.750
-6.760 (-1.93%)
182.500
-17.630 (-8.81%)
4101.000
+37.060 (+0.91%)
FAQs
What is the current price of Integra Lifesciences Holdings Corp (IART)?
The current price of Integra Lifesciences Holdings Corp (IART) is 14.82.
What is the symbol of Integra Lifesciences Holdings Corp?
The ticker symbol of Integra Lifesciences Holdings Corp is IART.
What is the 52-week high of Integra Lifesciences Holdings Corp?
The 52-week high of Integra Lifesciences Holdings Corp is 20.49.
What is the 52-week low of Integra Lifesciences Holdings Corp?
The 52-week low of Integra Lifesciences Holdings Corp is 8.70.
What is the market capitalization of Integra Lifesciences Holdings Corp?
The market capitalization of Integra Lifesciences Holdings Corp is 1.15B.
Is Integra Lifesciences Holdings Corp (IART) currently rated as Buy, Hold, or Sell?
According to analysts, Integra Lifesciences Holdings Corp (IART) has an overall rating of signal_hold, with a price target of 15.43.
What is the Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART)?
The Earnings Per Share (EPS TTM) of Integra Lifesciences Holdings Corp (IART) is -6.47.